Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8740988 | Journal of Microbiology, Immunology and Infection | 2017 | 9 Pages |
Abstract
The combination of tigecycline and colistin may be considered as a last-resort approach to the ESBL-producing KP infections, especially those isolates with carbapenem resistance.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Yee-Huang Ku, Chi-Chung Chen, Mei-Feng Lee, Yin-Ching Chuang, Hung-Jen Tang, Wen-Liang Yu,